Company ProfilePremium

Tayca Corporation

Company Profile Analysis

Ticker: 4027.Tテイカ株式会社

ESOMAR 23 Corporate BadgeISO Certifications Badge
Tayca Corporation - Company showcase

Year Founded & Workforce

1919

862 Employees

Tayca Corporation logo

Tayca Corporation Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Tayca Corporation Overview

ItemDetail
Legal nameテイカ株式会社 / TAYCA CORPORATION
Former names帝国人造肥料株式会社 (Teikoku Jinzo Hiryo, 1919–1942); 帝国化工株式会社 (Teikoku Kako, 1942–1989)
FoundedDecember 1919 (incorporated to manufacture superphosphate fertiliser)
Incorporation jurisdictionJapan (Companies Act); governance form: company with an Audit and Supervisory Committee
Registered head office1-3-47 Funamachi, Taisho-ku, Osaka 551-0022 (site of the Osaka Plant)
Corporate / IR office4-11-6 Tanimachi, Chuo-ku, Osaka (per Shared Research company profile)
Tokyo branchShin-Nihon Building 4F, 3-8-2 Nihonbashi, Chuo-ku, Tokyo
Exchange and tickerTokyo Stock Exchange Prime Market, securities code 4027 (listed May 1949; Prime since 4 April 2022)
ISIN / CUSIPno CUSIP for a TSE-only listing) — confirm with JPX
Fiscal year end31 March
Employees (consolidated)862 (31 March 2026); parent company 577
AuditorSeiryo Audit Corporation (清稜監査法人); continuous audit period 3 years; audit fee JPY 30M (FY3/2026)
Shares issued22,914,414 (after cancellation of 1,000,000 treasury shares on 27 May 2026)
Treasury shares252,831 (30 June 2026)
Share priceJPY 2,311 (close, 7 October 2026)
Market capitalisation≈JPY 52.4bn (22.66M shares outstanding ex-treasury at 30 June 2026 × JPY 2,311)
Websitehttps://www.tayca.co.jp/
Consolidated subsidiaries8 at 31 March 2026 (7 after the absorption of TFT Co., Ltd. on 1 April 2026)

The entity profiled is TAYCA CORPORATION (テイカ株式会社), Osaka, Japan, a listed company on the Prime Market of the Tokyo Stock Exchange. The "Public company" classification in the input list is correct.

MetricFY3/2026
Consolidated employees862
of which Functional Materials331
of which Electronic Materials & Chemicals349
of which Other112
of which Corporate70
Parent employees577
Parent average age (years)40.5
Parent average tenure (years)17.0
Parent average salary (JPY thousand)6,674

Source: FY3/2026 Yuho.

Tayca is a 107-year-old Osaka specialty-inorganic and fine-chemicals manufacturer that has evolved from a sulphuric-acid and fertiliser maker into a niche materials supplier built on three core technologies: inorganic/organic synthesis, particle surface treatment, and dispersion/stabilisation. Its legacy anchor is sulphate-process titanium dioxide pigment from the Okayama Plant, a commoditising business now under severe pressure from Chinese imports that forced a JPY 3.17bn impairment in FY3/2026. Around that core, Tayca built globally relevant niches: ultrafine titanium dioxide and zinc oxide used as mineral UV filters in sunscreens, oxidant/dopant chemistries for conductive-polymer capacitors used in vehicles and AI servers, linear alkylbenzene sulphonate surfactants produced in Japan, Thailand and Vietnam, and piezoelectric ceramics and single crystals for medical ultrasound via US subsidiary TRS Technologies. The May 2026 "MOVING-10 STAGE3" plan pivots capital toward electronics and medical piezo, restructures titanium dioxide, and commits at least JPY 20bn to shareholder returns.


The company's own description

In its FY3/2026 Annual Securities Report, Tayca describes the group as the parent plus eight consolidated subsidiaries whose principal business is the manufacture and sale of chemical industrial products and piezoelectric materials, plus the transport and storage of chemicals. Its corporate philosophy is to use the power of chemistry to create "sources of inspiration" and deliver dreams and smiles worldwide; the operating slogan in recruitment and IR materials is "まじめに感動素材" (earnestly creating inspiring materials). The company's statement of its value-creation logic, in the section on its basic policy on corporate control, traces a lineage from sulphuric-acid technology to titanium dioxide and surfactants, and from accumulated surface-treatment, dispersion and sulphonation know-how to high-value products such as cosmetic-grade ultrafine titanium oxide, surface-treated products and conductive-polymer agents for high-performance capacitors.

Independent characterisation

Tayca is best understood as a two-speed materials company. Roughly half of revenue (Functional Materials, JPY 26.2bn in FY3/2026) is titanium-dioxide-based: a commodity pigment line facing structural decline in Japan and price competition from Chinese sulphate- and chloride-route producers, and a higher-value cosmetic ultrafine-particle line exposed to inventory cycles at global sunscreen formulators. The other half (Electronic Materials & Chemicals, JPY 30.0bn in FY3/2026 on the old segment definition) combines a stable, low-growth ASEAN surfactant franchise with two genuinely growing technology niches: conductive-polymer capacitor chemicals and piezoelectric materials. The investment case therefore turns on whether the growth niches can scale fast enough, and whether management can stop the titanium-dioxide franchise from destroying value, while the balance sheet (68.9% equity ratio, JPY 17.6bn of investment securities) is recycled into returns.

Business and revenue model

DimensionCharacterisation
Revenue modelAlmost entirely product sales of manufactured chemicals and materials; minor service revenue from warehousing, logistics and plant engineering (Other segment, JPY 1.15bn external sales in FY3/2026). No subscription or licensing revenue is disclosed.
Production modelMake-to-stock; the company states it does not engage in build-to-order production (FY3/2026 Yuho).
Value-chain positionMid-stream intermediate/ingredient supplier. Buys ilmenite/titanium ore (imported), sulphur/sulphuric acid inputs, petrochemical alkylbenzene and specialty monomers; sells to paint, ink, plastics, cosmetics, detergent, capacitor and ultrasound-probe manufacturers.
Customer typesPaint makers (e.g., Kansai Paint, Dainichiseika, Dai Nippon Toryo, Asahipen, Kikusui Chemical — all disclosed as customers in the cross-shareholding register), global cosmetic/sunscreen formulators and OEMs, household-detergent and hair-care producers, chemical companies (NOF, Toho Chemical, Daiichi Kogyo Seiyaku, Sugai Chemical, Niitaka), capacitor manufacturers, medical ultrasound OEMs, and trading houses (Mitsubishi Corp., Mitsui & Co., Sumitomo Corp., Sojitz).
End-marketsArchitectural and industrial coatings, printing inks, plastics, paper; sunscreens and colour cosmetics; household detergents and personal care; automotive electronics, AI servers, telecom base stations, PCs/smartphones; medical diagnostic ultrasound; industrial sensors.
Purchased goodsJPY 1.63bn of merchandise purchased for resale in FY3/2026 (2.8% of sales), indicating a predominantly manufacturing model.

Production and sales by segment (FY3/2026, old segment basis)

Metric (JPY Mn)Functional MaterialsElectronic Materials & ChemicalsOtherTotal
Production value (at selling prices)25,75929,449055,208
YoY production change (%)-15.317.60-0.5
Merchandise purchases3121,31601,629
Sales26,21330,0071,15257,373
YoY sales change (%)-8.014.93.02.9

Source: FY3/2026 Yuho, Section "Production, Orders and Sales".

Strategy

Long-term vision "MOVING-10" (FY3/2021–FY3/2030)

Four basic policies (company): shift management resources to strong growth businesses; transform business structure in response to environmental change; create global-niche-top products; leverage group synergies. The original FY3/2030 aspiration of an operating margin of 15% or more and ROE of 12% or more (cited in the FY3/2025 Tanshin) has been replaced by STAGE3 targets of ROE of 8% or more and operating profit of JPY 4.5bn.

From STAGE2 to STAGE3

ItemSTAGE2 (May 2024) target for FY3/2027FY3/2026 actualSTAGE3 (May 2026) target for FY3/2030
Net sales (JPY 100M)680574590
Operating profit (JPY 100M)602245
Operating margin (%)948
ROE (%)7-18
EBITDA (JPY 100M)1056173

STAGE2 was terminated a year early. Management's own scorecard (STAGE3 plan, p.3) concluded that margin recovery failed (4% versus a 6% interim plan), selection and concentration remained incomplete because of Functional Materials weakness, new businesses struggled to commercialise, ROE stayed low and capital policy/IR were "still under consideration"; successes were a more-than-fourfold increase in conductive-polymer capacity versus FY3/2024 and an engagement score improvement.

STAGE3 framework

PillarInitiativeQuantified target (FY3/2027–FY3/2030 unless stated)
Electronic materialsConductive-polymer capacity completion (FY3/2027), next-generation capacitor technology, titania sol commercialisation, next-generation semiconductor/AI-infrastructure materialsElectronic-materials sales ≥2× FY3/2026 by FY3/2030 (130%+ in FY3/2027)
Medical & piezoelectricJapan–US dual manufacturing; single-crystal and ceramic technology upgrades; new uses and downstream entrySegment sales ≥JPY 6bn by FY3/2030; R&D JPY 3bn; capex ≥JPY 2bn; mass production from FY3/2029; segment OCF from JPY 0.8bn to 1.5bn
New businessRobotics, XR and bio; stage-gate governance; open innovation, VC, M&A, JVSales ≥JPY 1bn by FY3/2030; investment envelope ≥JPY 5bn
Functional materials reformCosmetics: overseas expansion to emerging brands and OEMs in Asia and South America, new high-value products, cost compression. Pigment TiO2: fixed/variable cost compression, pruning low-margin grades, price revisions, focus on key domestic customersSegment operating profit from −JPY 0.6bn to +JPY 0.4bn; segment OCF ≈JPY 1.8–2.0bn p.a.
Capital allocationCash in: OCF ≥JPY 27bn plus JPY 24bn from debt and cross-shareholding reductionGrowth capex ≥JPY 15bn (medical/electronics JPY 10bn, new business ≥JPY 5bn); maintenance JPY 16bn (equipment JPY 14bn, systems JPY 2bn); shareholder returns ≥JPY 20bn
Shareholder returnsDividend: higher of DOE 3% or 100% payout; buybacksBuybacks ≥JPY 10bn; early achievement of P/B ≥1.0x
Balance-sheet managementInventory-days reduction; receivable/payable terms; reduce policy shareholdings; use leverageInventory turnover shortened by 1 month
SystemsCost/budget/purchasing system renewal (FY3/2029), sales-logistics system renewal (FY3/2030)JPY 2bn system investment
Human capitalCareer development, talent management, training rebuildEngagement score 65 → 71
EnvironmentSBT certification; Scope 1–3 reduction; external ratingsScope 1+2 −42% and Scope 3 −25% by FY3/2031 vs FY3/2025 base; CDP climate A− and EcoVadis ≥70 by FY3/2030

Basic policies: (1) Business strategy — expand operating profit and realise new businesses; (2) Capital policy — capital efficiency and more aggressive business investment; (3) Strengthening the management foundation.

Near-term guidance

Guidance (JPY Mn)H1 FY3/2027 (revised 7 Aug 2026)FY3/2027 (13 May 2026, unchanged)
Net sales29,50059,500
Operating profit1,8002,500
Ordinary profit2,1002,900
Net income1,4001,800
EPS (JPY)61.3278.84
DPS (JPY)4080

The FY3/2027 guidance excludes any effect from Middle East tensions, which management said could not be reasonably estimated (FY3/2026 Yuho). Q1 operating profit of JPY 1.31bn already equals 52% of the full-year target, and the H1 guide was raised, while the full-year guide was left unchanged — a conservative stance.

Products & Services

Tayca does not publish price lists; pricing is negotiated B2B on a per-tonne or per-kilogram basis, and the company refers to periodic "price revisions" in its disclosures.

Functional Materials

Product lineDescription and capabilitiesTarget customersStatus / datesNotes
Pigment titanium dioxide (rutile and anatase; marketed under the TITANIX brand)Sulphate-process TiO2 white pigment produced at Okayama since 1951; grades tailored for paints, inks, plastics, paperDomestic architectural/industrial paint makers, ink and plastics compoundersMature; JPY 3.17bn impairment of related fixed assets in FY3/2026Company states volumes and sales fell in FY3/2026; partial price increases implemented; strategy is to focus on applications where Tayca grades are indispensable
Ultrafine titanium dioxide (MT-series)Rutile microparticle TiO2 with UV-scattering/absorbing function; particle-size and surface-treatment control for transparency, spreadability, water resistanceGlobal sunscreen and cosmetic formulators and OEMsDeveloped from the 1990s; continuously upgradedCompany and integrated-report summaries claim a global top position in sunscreen applications (company claim)
Ultrafine zinc oxide (MZ-series)Microparticle ZnO UV-A/UV-B filterSunscreen formulatorsAn "ultra-high-transparency" ultrafine ZnO was launched in FY3/2025 and is produced under GMP, with strong traction in the US (FY3/2026 Yuho)Benefits from the shift to mineral UV filters
Surface-treated products (cosmetic pigments)Organically/inorganically surface-modified powders, including O/W-sunscreen-compatible gradesColour-cosmetics and skincare formulatorsProduction since January 1996; Kumayama Plant built 2006Overseas customer destocking depressed FY3/2025–FY3/2026 sales
Spherical silica texture modifierMicroplastic-bead replacement with proprietary surface treatment giving a soft feel; a TiO2-encapsulated variant boosts SPFCosmetics formulatorsLaunched recently (FY3/2026 Yuho)Regulatory tailwind from microplastics restrictions
Titania sol (ultra-high refractive index)Nano-dispersed TiO2 sol for optical films combining high refractive index and transparencyDisplay and optical-component makersAdopted in optical members of the latest automotive displays (FY3/2026 Yuho); mass-production study under way; targeted at AR/VR devicesNamed STAGE3 "high value-added" growth theme
Photocatalyst and environmental-catalyst TiO2Ultrafine TiO2 for antifouling, deodorising and exhaust-gas reductionBuilding-materials and environmental-equipment makersEstablished—
Toner external additives and organic-inorganic composite powdersSurface-modified microparticles for toner flow, functional coatings, optical and electronic componentsToner and coatings makersEstablished/development—
Biomass titanium oxideTiO2 coated with silica extracted from rice husks to raise biomass content of packaging inksPackaging-ink makersDevelopment/early commercial (FY3/2026 Yuho)Sustainability-linked product
Sericite (via Japan Sericite Co.)Mica-group mineral used in cosmetics; JV procures raw material for TaycaCosmeticsJV established April 201750% owned, consolidated on control basis

Electronic Materials & Chemicals

Product lineDescription and capabilitiesTarget customersStatus / datesNotes
Conductive-polymer agents (導電性高分子薬剤)Oxidant/dopant and related formulations used to form the solid electrolyte of conductive-polymer capacitors, improving reliability and electrical characteristicsCapacitor manufacturers serving automotive electronics (EV, ADAS), AI servers, base stations, PCsStrong growth in FY3/2025–Q1 FY3/2027; JPY 1.5bn Osaka capacity expansion (start Dec 2024, completion Mar 2027); capacity raised to more than 4× the FY3/2024 level per STAGE2 reviewSTAGE3 targets electronic-materials sales of at least 2× FY3/2026 by FY3/2030; next-generation capacitor development under way
Surfactants (marketed under the TAYCAPOWER brand among others)Linear alkylbenzene sulphonic acid/sulphonates, solubilisers, industrial emulsifiers, acid-curing catalystsHousehold-detergent, shampoo and hair-care makers; industrial usersProduction at Osaka since 1961, Thailand since 2001, Vietnam since 2014Stable volume growth in FY3/2026 (detergents, hair care); ASEAN expansion is a stated priority
Sulphuric acidContact-process and refined sulphuric acidChemical industry; internal useSince 1938/1964Integrated with TiO2 sulphate process
Non-toxic anti-corrosive pigments (K-WHITE series)Heavy-metal-free (e.g., phosphate-based) rust-prevention pigmentsAutomotive and industrial coatingsPhosphate production since 1981Export weakness in FY3/2024–FY3/2025

Medical & Piezoelectric

Product lineDescription and capabilitiesTarget customersStatus / datesNotes
Piezoelectric ceramics (Japan)Lead-zirconate-titanate-type ceramics and processed elements for transducersMedical ultrasound probe makers; industrial sensor makersLong-establishedHorizontal deployment of ceramic and processing technology into non-healthcare sensors
Piezoelectric single crystals and devices (TRS Technologies, USA)Relaxor single-crystal materials and components with high electromechanical coupling for high-performance ultrasoundGlobal ultrasound OEMs; defence and industrial sensingAcquired January 2018Dual Japan–US manufacturing base; STAGE3 earmarks JPY 3bn of R&D and at least JPY 2bn of capex (FY3/2027–FY3/2030), with mass production of next-generation products from FY3/2029 (company "FY2028")

New business development themes

ThemeDescriptionStatus
Semiconductor encapsulant and polishing materialsMaterials for AI-era semiconductorsR&D (FY3/2026 Yuho)
Next-generation hazardous-substance adsorbentsLeveraging TiO2 shape and particle-size controlR&D
Robotics, XR, bioSTAGE3 target fields for new businessStage-gate process; ≥JPY 5bn investment envelope including M&A, JV and VC

Other (services)

ServiceProviderDescription
Warehousing and transportTayca Warehouse Co. (Osaka, Nishiyodogawa)Storage and logistics for Tayca products and third parties
Plant engineering and cargo handlingTayca M&M Co.Engineering for Tayca plants and handling services

Financial Narrative

All figures JPY M unless stated; FY3/2022 to FY3/2026. Sources: Kessan Tanshin FY3/2024 and FY3/2025, FY3/2026 Yuho, Yuho multi-year summaries; FY3/2022 items and cash-flow detail cross-checked against S&P Global Market Intelligence data (via StockAnalysis). Ratios are analyst calculations unless marked "company".

Income statement

No dilutive securities exist (company), so diluted EPS equals basic EPS. Company-stated EBITDA in the STAGE3 plan: JPY 6.7bn (FY3/2025) and JPY 6.1bn (FY3/2026), consistent with the calculation above. FY3/2021 revenue was JPY 38,402M (Yuho), used for the five-year CAGR.

Revenue CAGR: 8.4% p.a. over five years (FY3/2021 JPY 38.4bn to FY3/2026 JPY 57.4bn); 5.5% p.a. over four years from FY3/2022. Note that FY3/2021 was a COVID trough (−15.5% YoY), flattering the five-year rate.

Special items: FY3/2026 included a JPY 3,170M impairment loss (general-purpose TiO2 assets) and a deferred-tax benefit of JPY 790M. FY3/2023 and FY3/2024 included fixed-asset disposal losses of JPY 549M and 189M; FY3/2024–FY3/2025 included offsetting government subsidies and asset-compression losses (JPY 184M and 213M).

Commentary. The P&L shows a business that grew top-line through pass-through pricing (FY3/2022–FY3/2023) but has not converted it to profit. Gross margin compressed by 5.1 percentage points between FY3/2022 and FY3/2026 because raw material and fuel costs stayed high, titanium-dioxide volumes fell, and depreciation stepped up on new functional-particle capacity (D&A rose 23% in FY3/2026). Operating profit has oscillated between JPY 2.2bn and JPY 4.2bn, with the troughs (FY3/2024, FY3/2026) driven by different businesses: in FY3/2024 conductive polymers and surfactants slumped while cosmetics recovered; in FY3/2026 the reverse occurred. This negative correlation between segments has reduced volatility but also capped upside. Quarterly operating profit in FY3/2026 was JPY 957M, 450M, 48M and 721M — the near-zero Q3 triggered the February 2026 forecast cut and plan review.

Balance sheet

FY3/2022 total debt is derived from the S&P-reported net cash of JPY 8,055M; its short/long split and FY3/2022 current liabilities were not available. FY3/2026 BPS is calculated as JPY 60,972M equity / 22.83M shares. FY3/2026 short-term debt is the balance-sheet "short-term borrowings" line (JPY 6,568M), which on Tayca's presentation appears to include the current portion of long-term debt (analyst inference from the FY3/2026 cash-flow movements). Lender exposure disclosed in the cross-shareholding note: Mizuho group JPY 6,005M, MUFG group JPY 3,506M, Tomato Bank JPY 946M (31 March 2026).

Commentary. The balance sheet remains conservatively capitalised but is no longer net cash: three years of capex above operating cash flow, funded by JPY 15.7bn of new long-term borrowing (FY3/2023–FY3/2026), moved the group from JPY 8.1bn net cash to JPY 1.1bn net debt. Equity rose despite the FY3/2026 loss because unrealised gains on cross-shareholdings jumped JPY 3.7bn (Mitsubishi Corp. shares alone rose from JPY 3.2bn to JPY 6.5bn). The STAGE3 plan itself labels the equity ratio as excessive and identifies policy shareholdings, inventories and receivables as over-allocated capital.

Cash flow

Capex on an accrual (investment-decision) basis was JPY 4,721M in FY3/2026: Functional Materials 3,211, Electronic Materials & Chemicals 1,038, Other 164, corporate IT 307 (FY3/2026 Yuho).

Commentary. Cumulative five-year free cash flow was negative (−JPY 1.8bn) against cumulative dividends and buybacks of JPY 4.8bn — the gap was debt-funded. The FY3/2023 collapse in OCF reflected a JPY 4.7bn inventory build during the post-COVID supply squeeze. The FY3/2025–FY3/2026 capex peak (JPY 13.0bn over two years, more than twice depreciation) was concentrated in Functional Materials (new functional-particle plant, land of JPY 2.7bn acquired in FY3/2025) — capacity whose returns have so far disappointed, as demonstrated by the FY3/2026 profit decline in that segment.

Ratios

Third-party ROIC for FY3/2026 is 3.4–3.5% (S&P/StockAnalysis, EDINET DB) on different definitions. The company's STAGE3 plan cites an ROE series of 4% (FY3/2021), 6%, 6%, 3%, 4% and −1% (FY3/2026), consistent with the table.

Commentary. Returns are structurally below the cost of equity (S&P estimates WACC at 5.6%; Japanese specialty-chemicals investors typically assume a cost of equity of 7–8%). The cash conversion cycle of around 200 days is exceptionally long — roughly seven months of sales tied up in receivables and inventory — and the company targets a one-month reduction in inventory days plus renegotiation of collection terms. Each 30-day cut in DIO frees approximately JPY 4bn of cash at FY3/2026 cost levels (analyst estimate: JPY 48.4bn COGS / 365 × 30).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment (From Q1 FY3/2027) Overview

Segment (from Q1 FY3/2027)Contents

Functional Materials (機能性材料事業)

Pigment-grade titanium dioxide; ultrafine titanium dioxide; ultrafine zinc oxide; surface-treated products (cosmetics), titania sol, photocatalyst and toner-additive grades

Electronic Materials & Chemicals (電子材料・化成品事業)

Conductive-polymer agents for capacitors; surfactants (Japan, Thailand, Vietnam); sulphuric acid; non-toxic anti-corrosive pigments

Medical & Piezoelectric (医療・圧電関連事業) — new

Piezoelectric ceramics and single crystals (Japan and TRS Technologies, USA)

Other

Warehousing, transport, plant engineering and cargo handling (Tayca Warehouse, Tayca M&M)

Segment sales (JPY Mn)

Segment sales (JPY Mn)FY3/2023FY3/2024FY3/2025FY3/2026

Functional Materials

27,13028,07428,49526,213

Electronic Materials & Chemicals (incl. piezo)

26,28623,66326,12330,007

Other (external sales)

1,3551,2551,1181,152

Consolidated total

54,77352,99355,73757,373

Segment profit (JPY Mn)

Segment profit (JPY Mn)FY3/2023FY3/2024FY3/2025FY3/2026

Functional Materials

2,2215621,461-600

Electronic Materials & Chemicals (incl. piezo)

1,6861,4611,7842,500

Other

321327334300

Adjustments

-5-26-55-24

Consolidated operating profit

4,2242,3253,5252,176

Segment operating margin (%)

Segment operating margin (%)FY3/2023FY3/2024FY3/2025FY3/2026

Functional Materials

8.22.05.1-2.3

Electronic Materials & Chemicals

6.46.26.88.3

Consolidated

7.74.46.33.8

Segment sales YoY growth (%)

Segment sales YoY growth (%)FY3/2024FY3/2025FY3/2026

Functional Materials

3.51.5-8.0

Electronic Materials & Chemicals

-10.010.414.9

Other

-7.4-10.93.0

Share of consolidated sales (%)

Share of consolidated sales (%)FY3/2023FY3/2024FY3/2025FY3/2026

Functional Materials

49.553.051.145.7

Electronic Materials & Chemicals

48.044.746.952.3

Other

2.52.42.02.0

Segment sales (JPY 100M)

Segment sales (JPY 100M)FY3/2025FY3/2026FY3/2027 planFY3/2030 plan

Functional Materials

285262270260

Electronic Materials & Chemicals

222258264259

Medical & Piezoelectric

39424960

Other

11121211

Total

557574595590

Segment operating profit (JPY 100M)

FY3/2025

FY3/2026

FY3/2027 plan

FY3/2030 plan

Functional Materials

15-6-54

Electronic Materials & Chemicals

17232227

Medical & Piezoelectric

02612

Other

3322

Total

35222545

Revenue by Segment

Q1 segment data (JPY Mn)Q1 FY3/2026Q1 FY3/2027

Functional Materials sales

6,8497,397

Electronic Materials & Chemicals sales

5,6107,218

Medical & Piezoelectric sales

9481,261

Other external sales

272293

Consolidated sales

13,68116,170

Functional Materials profit

274283

Electronic Materials & Chemicals profit

566750

Medical & Piezoelectric profit

54216

Other profit

5957

Adjustment

3-1

Consolidated operating profit

9571,306

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

Metric (JPY Mn)FY3/2022FY3/2023FY3/2024FY3/2025FY3/2026

Revenue

46,36254,77352,99355,73757,373

Cost of sales

36,70944,33744,30145,55948,378

Gross profit

9,65310,4368,69210,1788,995

SG&A (incl. R&D)

6,0016,2116,3666,6526,817

Operating profit

3,6514,2242,3253,5252,176

Depreciation and goodwill amortisation

3,4553,4193,2023,1993,941

EBITDA (OP + D&A)

7,1067,6435,5276,7246,117

Ordinary profit

4,1564,7172,8023,7472,672

Pre-tax income

4,0934,2702,6853,514-971

Net income attributable to owners

2,8452,9861,8662,422-878

EPS basic (JPY)

122.79128.8680.60105.46-38.47

EPS diluted (JPY)

122.79128.8680.60105.46-38.47

Dividend per share (JPY)

3636383860

Margin (%)

Margin (%)FY3/2022FY3/2023FY3/2024FY3/2025FY3/2026

Gross margin

20.819.116.418.315.7

Operating margin

7.97.74.46.33.8

EBITDA margin

15.314.010.412.110.7

Net margin

6.15.53.54.3-1.5

Revenue growth YoY

20.718.1-3.35.22.9

Balance Sheet and Margin Analysis (%)

Metric (JPY Mn)FY3/2022FY3/2023FY3/2024FY3/2025FY3/2026

Total assets

72,12875,71782,70988,34588,558

Cash and deposits

13,06011,66114,30814,09211,273

Short-term debt (incl. current portion of LT debt)

—3,0503,8194,5536,568

Long-term debt

—3,8055,7107,9815,809

Total interest-bearing debt

5,0056,8559,52912,53412,377

Net debt (negative = net cash)

-8,055-4,806-4,779-1,5581,104

Total net assets

51,26353,65857,76459,40061,491

Shareholders' equity (excl. NCI)

50,89653,21957,28658,83460,972

Goodwill and intangibles

1,6281,5261,4101,149845

Investment securities

10,8739,27913,36512,23517,556

Inventories

14,32019,19618,21918,61318,103

Trade receivables (incl. e-notes)

14,08615,15016,26716,60317,571

Working capital (current assets − current liabilities)

—32,40334,97933,29031,711

Equity ratio (%, company)

70.670.369.366.668.9

BPS (JPY, company)

—2,296.452,489.062,578.372,670.00

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Cash Flow

Metric (JPY Mn)FY3/2022FY3/2023FY3/2024FY3/2025FY3/2026

Operating cash flow

4,8415814,9785,0564,541

Capital expenditure (PP&E purchases)

2,4732,6873,6177,3345,710

Free cash flow (OCF − capex)

2,368-2,1061,361-2,278-1,169

Dividends paid

830832832875910

Share buybacks

002523140

New long-term borrowing

04,0005,1556,5002,500

Long-term debt repaid

1,9542,1652,2143,4844,228

Change in working capital

-2,029-6,082-97-1,203-813

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY3/2022FY3/2023FY3/2024FY3/2025FY3/2026

ROE (%, company)

5.65.73.44.2-1.5

ROA (%, net income / avg. total assets)

4.04.02.42.8-1.0

ROIC (%, OP×(1−30%) / (net assets + debt − cash))

5.96.13.14.32.4

Current ratio (x)

—3.283.483.002.96

Debt / equity (x)

0.100.130.170.210.20

Net debt / EBITDA (x)

-1.13-0.63-0.86-0.230.18

Interest coverage (OP / interest expense, x)

107.481.227.027.515.3

Asset turnover (sales / avg. assets, x)

0.660.740.670.650.65

Days sales outstanding

110.9101.0112.0108.7111.8

Days inventory outstanding

142.4158.0150.1149.1136.6

Days payables outstanding

68.354.650.449.945.8

Cash conversion cycle (days)

185.0204.4211.7207.9202.6

Proxy Details

Proxy (JPY Mn)FY3/2026

TAYCA (Thailand) external sales

11,710

TAYCA (Thailand) ordinary profit

267

TAYCA (Thailand) net income

211

TAYCA (Thailand) net assets

4,124

TAYCA (Thailand) total assets

6,099

Region / Channel Details

Region / channelTrend and driver (source)

Japan — pigment TiO2

Declining: weak architectural-paint demand and import penetration (FY3/2024–FY3/2026 Yuho/Tanshin)

Overseas — pigment TiO2 exports

Declining: intensified competition from low-priced overseas producers, led by China (FY3/2026 impairment notice)

Overseas — cosmetic ultrafine particles

Volatile: strong FY3/2023 export recovery, then prolonged destocking in FY3/2025–FY3/2026; ultra-transparent ZnO gaining in the US

ASEAN — surfactants

Growing: Thai and Vietnamese subsidiaries reported strong household-detergent demand (FY3/2025, Q1 FY3/2027)

Overseas — piezoelectric

Growing: overseas medical-device customers strong; tariff-avoidance pre-stocking in FY3/2026

Global — conductive-polymer agents

Growing: automotive and AI-server capacitor demand (FY3/2025–Q1 FY3/2027)

Share-price reference (JPY)

Share-price reference (JPY)FY3/2022FY3/2023FY3/2024FY3/2025Oct-2026

Price

1,2901,1731,5201,3322,311

Performance Details

Performance (%)Value

52-week price change to 21 Jul 2026 (S&P)

88.1

Change vs FY3/2025 year-end reference

73.5

Change vs FY3/2024 year-end reference

52.0

Change vs FY3/2022 year-end reference

79.1

5-year beta (S&P)

0.44

Valuation Multiples

MultipleTaycaBasis

Market cap (JPY Bn)

52.4

22.66M shares ex-treasury

Enterprise value (JPY Bn)

53.7

Plus debt 11.3, minus cash 10.4, plus NCI 0.5 (30 Jun 2026)

P/E (FY3/2027E)

29.3

Company EPS guide JPY 78.84

P/E (FY3/2026)

n/m

Net loss

EV/EBITDA (FY3/2026)

8.8

EBITDA JPY 6.12bn

EV/EBITDA (FY3/2027 plan)

8.5

Plan EBITDA JPY 6.3bn

EV/Sales (FY3/2026)

0.94—

P/B

0.86

BPS JPY 2,696 (30 Jun 2026)

Dividend yield (%)

3.46

DPS JPY 80

Dividend metric

Dividend metricFY3/2022FY3/2023FY3/2024FY3/2025FY3/2026FY3/2027E

DPS (JPY)

363638386080

Payout ratio (%)

29.327.947.035.9

n/m

101.5

Total dividends (JPY Mn, company)

8348348788711,370—

Buybacks (JPY Mn)

0025231402,500

Analyst Conclusions

Management guidance

FY3/2027: sales JPY 59.5bn (+3.7%), OP JPY 2.5bn (+14.9%), NI JPY 1.8bn, DPS JPY 80. H1 raised to OP JPY 1.8bn after a Q1 OP of JPY 1.31bn. FY3/2030: OP JPY 4.5bn, ROE ≥8%, EBITDA JPY 7.3bn, flat sales of JPY 59bn — an explicit mix-and-margin plan rather than a volume plan.

Bull case

  1. Q1 run-rate beats guidance: annualising Q1 OP of JPY 1.31bn implies JPY 5bn+, double the full-year guide; even with H2 seasonality, upgrades look likely as conductive-polymer capacity comes online in March 2027.

  2. Mix shift toward high-margin niches: Medical & Piezo (17% Q1 margin) and electronics are growing 29–33% while the loss-making TiO2 asset base has already been written down, lowering future depreciation.

  3. Capital return of ≈40% of market cap over four years: ≥JPY 20bn of returns versus a JPY 52bn market cap, funded by cross-shareholding sales, supports the shares even with flat earnings.

Bear case

  1. Execution track record is poor: two consecutive plans (original MOVING-10 targets, STAGE2) were abandoned; FY3/2030 OP target of JPY 4.5bn is barely above FY3/2023's JPY 4.2bn.

  2. Pigment TiO2 can get worse: Chinese oversupply persists; further impairment or restructuring costs are possible, and Functional Materials is still loss-making (plan: −JPY 0.5bn in FY3/2027).

  3. Valuation already discounts recovery: 29x forward P/E and a 100%-payout dividend leave no margin for error; Q1 piezo strength may partly reflect tariff pre-buying that could reverse.

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
Nov 2026H1 FY3/2027 results: test of the raised H1 guide; possible full-year upgrade
Through Mar 2027Buyback execution pace against the JPY 2.5bn authorisation
Mar 2027Completion of Osaka conductive-polymer expansion
FY3/2027Cross-shareholding sales (Mitsubishi Corp., Kansai Paint stakes)
FY3/2027Any restructuring announcement for Okayama pigment TiO2
FY3/2027First new-business M&A/VC deployment under the ≥JPY 5bn envelope
May 2027FY3/2027 results and dividend confirmation; SBTi validation outcome
OngoingActivist-shareholder engagement; AGM voting on takeover-defence policy
OngoingCosmetic-customer inventory normalisation; US tariff developments affecting piezo

Concluding analyst verdict

Tayca is a company in transition from a century-old commodity-chemicals heritage to a portfolio of defensible micro-niches, and FY3/2026 was the year management finally acknowledged it. The JPY 3.17bn impairment of general-purpose titanium dioxide, the early abandonment of STAGE2 and the adoption of a DOE-3%-floor dividend with ≥JPY 10bn of buybacks represent a genuine break with the passive, cross-shareholding-heavy capital policy that held ROE between 3% and 6% for years. The operating evidence since the reset is encouraging: Q1 FY3/2027 delivered 18% sales growth and 36% operating-profit growth, with conductive-polymer agents and medical piezoelectric materials — businesses that barely registered a decade ago — now carrying the group.

The sceptic's objection is equally grounded in the record. Management has missed or abandoned every quantitative target set since 2020, invested heavily in Functional Materials capacity just before that segment fell into loss, and still runs a 200-day cash conversion cycle. The STAGE3 destination — JPY 4.5bn operating profit and 8% ROE by FY3/2030 — is modest, and the share price, up roughly 75–90% in a year, already prices in much of the capital-return story at nearly 30x guided earnings.

On balance, Tayca now offers a clearer and more investable proposition than at any time in the review period: a sub-1.0x P/B balance-sheet-unlock story with a growing electronics/medical engine and a binding dividend floor. The key swing factors are whether Functional Materials stops losing money, whether cross-shareholdings are actually sold to fund buybacks, and whether electronics growth survives a normalisation of AI-server and tariff-driven demand. Investors should treat the stock as a capital-policy and mix-shift story with real execution risk, and should monitor the November 2026 interim results and buyback pace as the first hard tests of management's new credibility.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitle (latest disclosure)ResponsibilityBackgroundBoard tenure

Shunji Idei (出井俊治)

Representative Director, President & CEO

Internal Audit; Osaka and Okayama Research Institutes

Born 24 Mar 1964 (age 62). Joined Tayca 1986; Head of Okayama Research Institute 2012; Sales Dept. GM 2015; Tokyo Branch GM 2017; Director 2018; President of TFT 2018; Managing EO 2020; Senior Managing EO 2021; CEO since June 2022

Director since 2018

Tamataro Iwasaki (岩崎多摩太郎)

Director, Managing Executive Officer

Environmental Management Planning, Materials, Osaka Plant

Former President of Tayca Warehouse

Director since June 2020

Yoshihiro Murata (村田悦宏)

Director, Managing Executive Officer

Sales

Former Tokyo Branch GM

Director since June 2022

Hiroshi Nakamura (中村弘)

Director, Senior Executive Officer

General Affairs, HR, Accounting, DX

Investor-relations contact

Director since June 2025

Masahiko Tauchi (田内雅彦)

Director, Senior Executive Officer (nominated)

—

Senior Executive Officer

Nominated for election at the 24 June 2026 AGM

Kosuke Nakatsuka (中務康介)

Director (full-time Audit & Supervisory Committee member)

Audit

Former Managing EO, General Affairs and HR

Director since June 2022; ASC member since June 2025

Koji Yamamoto (山本浩二)

Outside Director (ASC)

Audit

Corporate-management experience (per Yuho characterisation of outside directors)

—

Mamiko Ozaki (尾﨑まみこ)

Outside Director (ASC)

Audit

Academic / technical-research or legal-accounting expertise (Yuho describes the four outside directors collectively)

—

Takeshi Inoue (井上剛)

Outside Director (ASC)

Audit

As above

—

Reiko Furushima (古島礼子)

Outside Director (ASC)

Audit

As above

Since June 2025

Directors' Remuneration

ItemDetail

Board size

9 directors (4 outside) at 31 March 2026; 10 (4 outside) if the June 2026 AGM slate was approved

Independence

44% outside (FY3/2026); 40% after the AGM

Female directors

2 of 9 (22.2%)

Chair / CEO separation

No separate chair disclosed; the President & CEO presides

Audit & Supervisory Committee

5 members (1 full-time internal, 4 outside); 11 meetings in FY3/2026

Nomination & Compensation Committee

6 members (2 internal, 4 outside), chaired by the CEO; 4 meetings in FY3/2026

Board meetings

14 in FY3/2026; attendance 100% for all except one retiring outside director

Other bodies

Management Committee (monthly), Sustainability Committee (CEO-chaired, ≥2/yr), Risk Management Committee, Compliance Committee

Internal audit

Internal Audit Office (2 staff)

Board & Management Changes

DateChangeContext

Jun 2019

Hirofumi Yamazaki (ex-Mizuho/Dai-Ichi Kangyo Bank) becomes Representative Director

Move to Audit & Supervisory Committee structure

Jun 2020

Yamazaki becomes President & CEO; Masao Nagita Chairman

Launch of MOVING-10

Jun 2022

Shunji Idei (career Tayca engineer/salesman) becomes President & CEO; Yamazaki becomes special adviser; Nagita becomes non-executive director

Stated aim: generational renewal and faster response

Jun 2025

Akira Miyazaki and Hitoshi Tanaka retire; Hiroshi Nakamura and Reiko Furushima join

Routine rotation

Jun 2026

Masahiko Tauchi nominated as Director & Senior EO

Coincides with STAGE3 reorganisation

Major Shareholders

RankShareholderStake (%)Shares
1

Mitsui & Co., Ltd.

7.811,784,000
2

The Master Trust Bank of Japan (trust account)

7.281,661,000
3

Mitsubishi Corporation

7.141,630,000
4

Yamada Sangyo Co., Ltd.

6.441,470,000
5

Mizuho Trust & Banking (retirement-benefit trust for Mizuho Bank)

4.421,009,000
6

Tayca Group Employee Shareholding Association

4.00914,000
7

Chuo-Nittochi Co., Ltd.

3.04694,000
8

Kansai Paint Co., Ltd.

2.68612,000
9

Sumitomo Corporation

2.19500,000
10

Custody Bank of Japan (trust account)

1.84419,000

Competitive Landscape

Competitors by Segment

BusinessCompetitorPositioning vs Tayca

Pigment TiO2

Ishihara Sangyo Kaisha (TSE 4028)

Japan's largest TiO2 producer and its only chloride-process maker; diversified into agrochemicals; far more profitable

Pigment TiO2

Sakai Chemical Industry (TSE 4078)

Domestic TiO2 and functional inorganic chemicals; also cosmetic-grade particles

Pigment TiO2

Chinese producers (e.g., LB Group)

Low-cost, large-scale sulphate and chloride capacity; cited by Tayca as the main source of price pressure

Pigment TiO2

Tronox, Chemours, Kronos, Venator

Global chloride-process majors; scale and cost leaders outside China

Cosmetic ultrafine TiO2/ZnO

Sakai Chemical; Ishihara Sangyo

Domestic peers with cosmetic grades

Cosmetic ultrafine TiO2/ZnO

Croda, BASF, Kobo Products, Sumitomo Osaka Cement

Global ingredient suppliers/dispersers; Tayca competes on particle-control and surface-treatment know-how

Conductive-polymer materials

Heraeus (Clevios PEDOT), Shin-Etsu Polymer, Nagase ChemteX

Global PEDOT dispersion/material suppliers; Tayca's niche is capacitor-electrolyte oxidant/dopant agents

Surfactants

Kao, Lion Specialty Chemicals, Sanyo Chemical, and ASEAN LAS producers

Larger integrated surfactant makers; several domestic chemical firms (NOF, Toho Chemical, Daiichi Kogyo Seiyaku) are Tayca customers rather than direct rivals

Piezoelectric materials

CTS Corporation, CeramTec, PI Ceramic, Fuji Ceramics, Murata, TDK

Ceramic and single-crystal suppliers to ultrasound and sensor OEMs

Peer Comparison

MetricTaycaIshihara SangyoSakai Chemical

Revenue (JPY Mn)

57,373154,89781,447

Revenue growth (%)

2.96.7-3.5

Operating margin (%)

3.812.37.9

ROE (%)

-1.513.73.5

R&D intensity (%)

2.0——

Equity ratio (%)

68.953.7—

Impairment in FY3/2026 (JPY Mn)

3,170—2,982

Company Snapshot

$383.3M

Revenue

862

Employees

1919

Founded

SWOT Analysis

Strengths

  • Fortress balance sheet: equity ratio 68.9% and net debt of only JPY 1.1bn at 31 March 2026, plus JPY 17.6bn of investment securities (FY3/2026 Yuho).
  • Fast-growing electronics niche: Electronic Materials & Chemicals sales +14.9% in FY3/2026 and +28.7% in Q1 FY3/2027, driven by conductive-polymer agents for AI servers and vehicles.
  • High-margin medical piezo business: Q1 FY3/2027 segment profit of JPY 216M on JPY 1.26bn sales (17.1% margin), quadrupled year on year.
  • Cosmetic UV-filter know-how: ultra-transparent ultrafine ZnO launched FY3/2025 under GMP, with strong US uptake (FY3/2026 Yuho).
  • Geographic production diversity: four manufacturing countries; Thailand alone ≈20% of group sales.
  • Credible shareholder-return commitment: DOE ≥3% dividend floor (JPY 80 DPS for FY3/2027, 3.5% yield) and ≥JPY 10bn of buybacks, equal to about 19% of current market capitalisation.

Weaknesses

  • Structurally low returns: ROE ≤5.7% in every year FY3/2022–FY3/2026 and −1.5% in FY3/2026.
  • Impaired legacy core: JPY 3.17bn impairment on general-purpose TiO2; Functional Materials segment loss of ≈JPY 0.6bn in FY3/2026.
  • Poor capital-allocation track record: JPY 13.0bn capex in FY3/2025–FY3/2026, much of it in Functional Materials, followed by that segment's decline; five-year cumulative FCF negative.
  • Bloated working capital: cash conversion cycle ≈203 days (FY3/2026).
  • Repeated forecast misses: FY3/2024 guide cut from OP JPY 4.8bn to 2.4bn; FY3/2026 guide cut from 3.3bn to 1.7bn; STAGE2 abandoned a year early.
  • Low gender diversity in management: women hold 1.4% of parent-company management posts versus a 5% target for March 2027.

Opportunities

  • AI-server capacitor demand: management guides electronic-materials sales to at least double by FY3/2030.
  • Optics: titania sol adoption in automotive displays opens AR/VR optical-film applications.
  • Medical-ultrasound expansion: STAGE3 targets JPY 6bn segment sales with mass production of next-generation materials from FY3/2029.
  • Balance-sheet unlocking: JPY 17.3bn of listed cross-shareholdings (Mitsubishi Corp. JPY 6.5bn, Kansai Paint JPY 6.1bn) can fund buybacks.
  • Working-capital release: a one-month inventory-days cut could free roughly JPY 4bn.
  • Activist and TSE-reform pressure: multiple activist filings in 2026 and the P/B ≥1.0x target create a catalyst for further capital action.

Threats

  • Chinese TiO2 overcapacity could force further impairments or exit costs at Okayama.
  • Cosmetic-customer destocking could recur, as in FY3/2025–FY3/2026.
  • Raw-material and energy volatility: imported titanium ore and petrochemical feedstock; management excluded Middle East effects from FY3/2027 guidance.
  • US trade policy: tariffs affecting piezo flows (FY3/2026 pre-buying may reverse) and exports.
  • Technology substitution in capacitor electrolytes or ultrasound transducers (e.g., CMUT/PMUT silicon transducers) could erode niches.
  • Regulatory tightening of chemical substances, including scrutiny of nano-TiO2 in cosmetics and of lead-based piezo ceramics.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
14 May 2025FY3/2025 results: sales JPY 55.7bn (+5.2%), OP JPY 3.53bn (+51.6%); FY3/2026 guidance JPY 59.0bn / OP 3.3bn; DPS guidance 40Recovery year; guidance later missed
14 May 2025Director and executive-officer changes announcedBoard rotation
25 Jun 2025159th AGM; H. Nakamura and R. Furushima electedBoard refresh
26 Jun 2025FY3/2025 Yuho filedAnnual filing
25 Jul 2025Restricted-stock compensation for executive officers introducedAlignment of pay with share price
8 Aug 2025Q1 FY3/2026: sales +0.5%, OP −17.9%, NI −22.7%Early signs of Functional Materials weakness
21 Aug 2025Restricted-stock disposal payment completedPlan implementation
12 Nov 2025H1 FY3/2026: sales JPY 27.1bn, OP JPY 1.41bn (vs JPY 1.7bn guide)H1 miss
3 Dec 2025Board resolves absorption of TFT Co., Ltd.Simplification
Jan 2026SAMARANG UCITS change report (4.43%)Engagement-oriented foreign investor on register
6 Feb 2026Q3 FY3/2026: quarterly OP just JPY 48MProfit trough
6 Feb 2026FY3/2026 guidance cut to sales 58.0bn / OP 1.7bn / NI 1.3bnDowngrade
6 Feb 2026STAGE2 review announced; FY3/2026 DPS raised to JPY 60; shareholder-return policy changedCapital-policy pivot under pressure
Feb 2026Mizuho Bank change report (4.22%); SBTi target validation applied forOwnership and ESG
Mar 2026Mikikuro Uejima initial large-shareholding report (3.80%)Individual activist investor on register
1 Apr 2026TFT merger effectiveReorganisation
13 May 2026FY3/2026 results: sales JPY 57.4bn (record), OP JPY 2.18bn (−38.3%), net loss JPY 0.88bnFirst loss in the review period
13 May 2026JPY 3.17bn impairment on general-purpose TiO2Recognition of structural decline
13 May 2026"MOVING-10 STAGE3" announced; STAGE2 terminated earlyStrategic reset
13 May 2026Buyback of up to 1.5M shares / JPY 2.5bn (to 19 Mar 2027); cancellation of 1.0M sharesReturn of capital
13 May 2026FY3/2027 guidance: sales 59.5bn, OP 2.5bn, NI 1.8bn; DPS JPY 80Policy-driven 33% dividend increase
13 May 2026Takeover-defence policy renewal proposed; M. Tauchi nominated as directorGovernance
14 May 2026Dividend received from a consolidated subsidiary disclosedCash repatriation
27 May 20261,000,000 treasury shares cancelled (4.18% of issued)Share count falls to 22.91M
3 Jun / 1 Jul / 4 Aug 2026Monthly buyback progress: 169,100 shares for JPY 375M by 30 JuneExecution
23 Jun 2026FY3/2026 Yuho filedAnnual filing
24 Jun 2026160th AGM (10-director slate; defence-plan renewal)–
Jul 2026DOE 5 Percent Co. change report (1.69%)Activist position change
24 Jul 2026Restricted-stock disposal announcedCompensation
7 Aug 2026Q1 FY3/2027: sales JPY 16.2bn (+18.2%), OP JPY 1.31bn (+36.4%), NI JPY 1.23bn (+63.6%); new three-segment reportingStrong start; piezo profit quadrupled
7 Aug 2026H1 FY3/2027 guidance raised (OP 1.8bn); FY unchangedConservative full-year stance
19 Aug 2026Shared Research report updatedSponsored coverage
Jul–Oct 2026Share price up 88% over 52 weeks (to 21 Jul 2026); JPY 2,311 on 7 Oct 2026Re-rating on capital policy

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

9 charts
Income Statement: Revenue & Gross Profit: Revenue rose from JPY 46,362 Mn in 2022 to JPY 57,373 Mn in 2026.
Tayca Corporation — Income Statement: Revenue & Gross Profit
Series (JPY Mn)20222023202420252026
Revenue46,36254,77352,99355,73757,373
Cost of sales36,70944,33744,30145,55948,378
Gross profit9,65310,4368,69210,1788,995

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. TAYCA FY3/2026 Annual Securities Report (Yuho), via EDINET DB · EDINET original
  2. FY3/2026 results analysis (EDINET DB) (edinetdb.jp)
  3. Kessan Tanshin FY3/2025 (14 May 2025) (www2.jpx.co.jp)
  4. Kessan Tanshin FY3/2024 (10 May 2024) (www2.jpx.co.jp)
  5. Kessan Tanshin Q1 FY3/2026 (8 Aug 2025) (www2.jpx.co.jp)
  6. Kessan Tanshin Q1 FY3/2027 (7 Aug 2026) (finance-frontend-pc-dist.west.edge.storage-yahoo.jp)
  7. Impairment and forecast-variance notice (13 May 2026) (www2.jpx.co.jp)
  8. Medium-Term Plan "MOVING-10 STAGE3" (13 May 2026) (www2.jpx.co.jp)
  9. Medium-Term Plan "MOVING-10 STAGE2" (10 May 2024) (www2.jpx.co.jp)
  10. Buyback and cancellation notice (13 May 2026) (www2.jpx.co.jp)
  11. Buyback status (1 Jul 2026) (www2.jpx.co.jp)
  12. Cancellation completion (27 May 2026) (www2.jpx.co.jp)
  13. Buyback completion (19 Mar 2025) (www2.jpx.co.jp)
  14. Officer changes (13 May 2026) (www2.jpx.co.jp)
  15. CEO succession notice (2022) (www2.jpx.co.jp)
  16. CEO succession notice (2020) (www2.jpx.co.jp)
  17. MOVING-10 launch (23 Jun 2020) (www2.jpx.co.jp)
  18. TSE disclosure list (Kabutore) (kabutore.biz)
  19. StockAnalysis (S&P Global data): income statement · balance sheet · cash flow · statistics
  20. Yahoo! Finance Japan (price, Q1 summary) (finance.yahoo.co.jp)
  21. Matsui Securities quarterly data (finance.matsui.co.jp)
  22. Kabutan (FY3/2026 results news) (s.kabutan.jp)
  23. Logmi Finance (officers, shareholders) (finance.logmi.jp)
  24. Kitaishihon (integrated-report summary, product glossary) (kitaishihon.com)
  25. Shared Research (company page) (sharedresearch.jp)
  26. J-LIC company profile (j-lic.com)
  27. Traders Web price history (traders.co.jp)
  28. Ishihara Sangyo FY3/2026 (EDINET DB) (edinetdb.jp)
  29. Sakai Chemical FY3/2026 (EDINET DB) (edinetdb.jp)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.